NDC 21695-726

Orphenadrine Citrate, Aspirin and Caffeine

Orphenadrine Citrate, Aspirin And Caffeine

Orphenadrine Citrate, Aspirin and Caffeine is a Oral Tablet, Multilayer in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Orphenadrine Citrate; Aspirin; Caffeine.

Product ID21695-726_8e41b33e-f71f-4a5e-b88f-cdfefb2bee20
NDC21695-726
Product TypeHuman Prescription Drug
Proprietary NameOrphenadrine Citrate, Aspirin and Caffeine
Generic NameOrphenadrine Citrate, Aspirin And Caffeine
Dosage FormTablet, Multilayer
Route of AdministrationORAL
Marketing Start Date1996-12-31
Marketing CategoryANDA / ANDA
Application NumberANDA074654
Labeler NameRebel Distributors Corp
Substance NameORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
Active Ingredient Strength50 mg/1; mg/1; mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-726-45

45 TABLET, MULTILAYER in 1 BOTTLE (21695-726-45)
Marketing Start Date1996-12-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-726-45 [21695072645]

Orphenadrine Citrate, Aspirin and Caffeine TABLET, MULTILAYER
Marketing CategoryANDA
Application NumberANDA074654
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-12-31
Inactivation Date2019-09-24

NDC 21695-726-30 [21695072630]

Orphenadrine Citrate, Aspirin and Caffeine TABLET, MULTILAYER
Marketing CategoryANDA
Application NumberANDA074654
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-12-31
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
ORPHENADRINE CITRATE50 mg/1

OpenFDA Data

SPL SET ID:8e41b33e-f71f-4a5e-b88f-cdfefb2bee20
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 994535
    • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
    • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]

    NDC Crossover Matching brand name "Orphenadrine Citrate, Aspirin and Caffeine" or generic name "Orphenadrine Citrate, Aspirin And Caffeine"

    NDCBrand NameGeneric Name
    21695-726Orphenadrine Citrate, Aspirin and CaffeineOrphenadrine Citrate, Aspirin and Caffeine
    71993-304Orphenadrine Citrate, Aspirin and CaffeineOrphenadrine Citrate, Aspirin and Caffeine
    71993-999Orphenadrine Citrate, Aspirin and CaffeineOrphenadrine Citrate, Aspirin and Caffeine
    74157-999Orphenadrine Citrate, Aspirin and Caffeineorphenadrine citrate, aspirin and caffeine
    61825-305NorgesicOrphenadrine Citrate, Aspirin and Caffeine
    50991-999Norgesic ForteOrphenadrine Citrate, Aspirin and Caffeine
    61825-302ORPHENGESIC FORTEOrphenadrine Citrate, Aspirin and Caffeine
    61825-999Orphengesic ForteOrphenadrine Citrate, Aspirin and Caffeine
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.